JPMorgan shares fall as mixed outlook sours profit beat

By Anirban Sen and Matt Scuffham

Jan 14 (Reuters) - JPMorgan Chase & Co JPM.N posted fourth-quarter profit ahead of market expectations on Friday, but its shares fell as much as 6% as analysts expressed disappointment over its forecasts for future profitability.

The country's largest bank warned that its return on tangible capital equity (ROTCE), a key metric which measures how well a bank uses shareholder money to produce profit, may fall below its medium-term target of 17% this year.

A slowdown in capital markets activity, the cost of investing in the business, including new technology and branch openings, and rising expenses due in part to higher inflation and labor costs, were some of the factors the bank cited as headwinds in the coming year.

However, it retained a medium-term target for 17% ROTCE beyond 2022, saying it expected to benefit from rising interest rates and the longer-term growth of businesses resulting from its investments.

That guidance disappointed some analysts and investors. Shares in JPMorgan, which had enjoyed a strong run leading up to the results, were down 5% in mid-morning trading, the biggest faller among U.S. banking stocks.

The bank reported a 14% drop in fourth quarter profit compared with a year ago, reflecting a decline in trading revenues. The previous year had benefited from increased trading activity, as the Federal Reserve's stimulus measures produced more liquidity in equity and fixed income markets.

The Fed began scaling back its asset purchases in November 2021, resulting in lower trading volumes.

Markets revenues fell by 11% during the quarter. Fixed income markets revenue was down 16% with equity markets revenue 2% lower.

That slowdown was only partially offset by a stellar performance at JPMorgan's investment bank, where revenue rose 28% and a 6% increase in loan growth across the firm.

Over the past year, large U.S. lenders benefited from higher consumer spending and a surge in deal-making driven by loose monetary policy, while their trading arms gained from exceptional volatility in financial markets.

However, soaring inflation, a potential Omicron-induced economic slowdown and trading revenues returning to normal levels are set to challenge the banking industry's growth in the coming months.

JPMorgan's Chief Executive Jamie Dimon and Chief Financial Officer Jeremy Barnum faced tough questions from analysts on a conference call after the results.

Wells Fargo analyst Mike Mayo expressed frustration that the bank was unable to achieve its ROTCE target this year and over the length of time it will take for investments to feed through to the bottom line.

"You're saying we have to wait two years for the 17% ROTCE despite the booming economy," Mayo said. "You're in there for the long term but a lot of investors aren't planning to invest for a 10-year horizon."

Dimon responded, "I feel your pain and frustration. It is very possible in 2023 we'll have a 17% ROTCE. It depends on how we deploy our capital, on fixed income markets, a bunch of stuff."


Analysts also expressed concern about spiraling expenses.

During the quarter, non-interest expense jumped 11% to nearly $18 billion, driven largely by higher staff compensation.

Banks are facing cutthroat competition to hire and are being forced to pay more to recruit and keep talent.

"We want to be very, very competitive on pay," Dimon said. "If that squeezes margins so be it."

During the quarter, JPMorgan maintained its position as the second-biggest provider of worldwide M&A advisory after Goldman Sachs, according to Refinitiv. The league tables rank financial services firms by the amount of M&A fees they generate.

Barnum said JPMorgan expects a "modest normalization" in investment banking revenue in 2022, but added that the overall deals pipeline remains healthy.

On the slowdown in trading, Barnum said the bank expects some normalization this year but still expects revenue to remain above 2019 levels.

Overall, the lender posted a profit of $10.4 billion, or $3.33 per share, in the quarter ended Dec. 31. Analysts had estimated $3.01 per share, according to Refinitiv data.

Reporting by Anirban Sen in Bengaluru and Matt Scuffham in New York; Editing by Saumyadeb Chakrabarty and Nick Zieminski

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.